Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03208452
Other study ID # B1605/346-002
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date March 19, 2017
Est. completion date December 19, 2018

Study information

Verified date September 2023
Source Seoul National University Bundang Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study designed to evaluate the correlation between the effect of intraoperative magnesium sulfate infusion and the incidence of emergence agitation after pediatric ophthalmic surgery


Description:

Emergence agitation (EA) is a frequent postoperative complication in pediatric patients after general anesthesia. There are several suggested causes of EA and pain has been considered one of them. Magnesium is an N-methyl-D-aspartate (NMDA) receptor antagonist and increasingly used as an analgesic-adjuvant. We evaluate the Pediatric Anesthesia Emergence Delirium (PAED) Scale to investigate whether the intraoperative infusion of magnesium sulfate reduces the incidence of EA in pediatric patients who undergo ophthalmic outpatient surgery.


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date December 19, 2018
Est. primary completion date December 19, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 4 Years to 7 Years
Eligibility Inclusion Criteria: - pediatric patients who are planned to operate ophthalmic surgery under general anesthesia aged 4-7 years Exclusion Criteria: - ASA class = III - imbalance of electrolyte - myocardial damage or conduction abnormality on ECG - myasthenia gravis or any other neuromuscular disease - impaired renal function - denial to participate in study or not be able to give informed consent

Study Design


Intervention

Drug:
Magnesium Sulfate
Comparing the effect of continuous infusion magnesium sulfate and normal saline in the occurrence of emergence agitation
Normal saline
Comparing the effect of continuous infusion magnesium sulfate and normal saline in the occurrence of emergence agitation

Locations

Country Name City State
Korea, Republic of Seoul National University Bundang Hospital Seongnam-si

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Bundang Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary the incidence of emergence agitation (EA) Using PAED (pediatric anesthesia emergence delirium) score, consider the score 10 or more as occuring of EA. Comparing the score between the placebo group and the intervention group for the difference of the incidence of EA. 15 minute interval at the post-anesthetic care unit (PACU)
Secondary the severity of EA Comparing the maximal PAED score between the placebo group and the intervention group for evaluating difference of severity of EA. 15 minute interval at the post-anesthetic care unit (PACU)
See also
  Status Clinical Trial Phase
Terminated NCT03110900 - Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation Phase 4
Completed NCT05272501 - CAlming Touch for People With Agitation or Other Behavioural Symptoms of DEMentia - A Randomized Feasibility Trial N/A
Completed NCT06041646 - Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder Phase 4
Completed NCT06217146 - A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia. N/A
Recruiting NCT05543681 - IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's Phase 2
Recruiting NCT03513549 - Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder
Active, not recruiting NCT05658510 - Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) Phase 3
Not yet recruiting NCT05612711 - Dronabinol for Agitation in Dementia Crossover Trial Phase 2
Recruiting NCT04957238 - Physical Restraints in Intensive Care Unit Patients N/A
Terminated NCT03899506 - Olanzapine Versus Midazolam for Agitation
Completed NCT03211897 - Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation N/A
Recruiting NCT05783505 - A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use N/A
Completed NCT04053426 - Agitation Follow up After Introduction of a New Patient Care Algorithm
Completed NCT03226522 - Addressing Dementia Via Agitation-Centered Evaluation Phase 2/Phase 3
Recruiting NCT03926520 - Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD) N/A
Recruiting NCT04075435 - Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia Early Phase 1
Completed NCT04276883 - Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder Phase 3
Completed NCT04797715 - Assessing Clinical Outcomes in Alzheimer's Disease Agitation Phase 3
Completed NCT04251910 - Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia Phase 1/Phase 2
Recruiting NCT05765162 - Safe Brain Initiative, Operationalizing Precision Anaesthesia